VN1R80P

Across TCGA pan-cancer cohorts, VN1R80P RNA differs between tumor and matched normal tissue in 7 of 18 cancer types tested, making tumor–normal expression one of VN1R80P’s most consistent transcriptional readouts.

The strongest signal is observed in kidney renal clear cell carcinoma (KIRC), where VN1R80P RNA is more highly expressed in tumor relative to normal tissue. In most cancer types VN1R80P is over-expressed in tumor.

KIRC, KIRP, and THCA are the cancer types where VN1R80P tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in VN1R80P RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
KIRC	All	All	+0.097	.006	5	view →
KIRP	Female	All	+0.192	.006	4	view →
THCA	Male	All	+0.418	.017	2	view →
CHOL	All	All	+0.231	.003	2	view →
COAD	Female	All	+0.195	.014	2	view →
HNSC	Male	All	+0.127	.045	1	view →
LUSC	All	All	+0.117	.034	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 7 strongest of 7 lineages.

VN1R80P–KIRC

Open the KIRC breakdown →